222 related articles for article (PubMed ID: 18434044)
1. Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS).
Stoové MA; Dietze PM; Aitken CK; Jolley D
Drug Alcohol Depend; 2008 Aug; 96(3):281-5. PubMed ID: 18434044
[TBL] [Abstract][Full Text] [Related]
2. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA
AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910
[TBL] [Abstract][Full Text] [Related]
3. [Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy].
Muga R; Egea JM; Navío M; Sirera G; Vall M; Tor J
Med Clin (Barc); 1999 May; 112(19):721-5. PubMed ID: 10394568
[TBL] [Abstract][Full Text] [Related]
4. Gender differences among regular injecting drug users in Sydney, Australia, 1996-2003.
Breen C; Roxburgh A; Degenhardt L
Drug Alcohol Rev; 2005 Jul; 24(4):353-8. PubMed ID: 16234131
[TBL] [Abstract][Full Text] [Related]
5. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
6. Drug use and risk among regular injecting drug users in Australia: does age make a difference?
Degenhardt L; Kinner SA; Roxburgh A; Black E; Bruno R; Fetherston J; Fry CL
Drug Alcohol Rev; 2008 Jul; 27(4):357-60. PubMed ID: 18584384
[TBL] [Abstract][Full Text] [Related]
7. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
[TBL] [Abstract][Full Text] [Related]
8. Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data.
Stoové MA; Dietze PM; Jolley D
Drug Alcohol Rev; 2009 Jul; 28(4):347-52. PubMed ID: 19594787
[TBL] [Abstract][Full Text] [Related]
9. HIV prevalence among injection drug users in rural Guangxi China.
Liu W; Chen J; Rodolph M; Beauchamp G; Mâsse B; Wang S; Li R; Ruan Y; Zhou F; Leung MK; Lai S; Shao Y; Jackson JB
Addiction; 2006 Oct; 101(10):1493-8. PubMed ID: 16968351
[TBL] [Abstract][Full Text] [Related]
10. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia.
Degenhardt L; Black E; Breen C; Bruno R; Kinner S; Roxburgh A; Fry C; Jenkinson R; Ward J; Fetherston J; Weekley J; Fischer J
Drug Alcohol Rev; 2006 Sep; 25(5):403-12. PubMed ID: 16939934
[TBL] [Abstract][Full Text] [Related]
11. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
[TBL] [Abstract][Full Text] [Related]
12. [An 1-year prospective cohort study on mortality of injecting drug users].
Zhang L; Ruan YH; Jiang ZQ; Yang ZN; Liu SZ; Zhou F; He YX; Yin L; Qin GM; Shao YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Mar; 26(3):190-3. PubMed ID: 15941506
[TBL] [Abstract][Full Text] [Related]
13. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
Larance B; Degenhardt L; Copeland J; Dillon P
Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
[TBL] [Abstract][Full Text] [Related]
14. Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users.
Dwyer R; Topp L; Maher L; Power R; Hellard M; Walsh N; Jauncey M; Conroy A; Lewis J; Aitken C
Drug Alcohol Depend; 2009 Feb; 100(1-2):9-16. PubMed ID: 19013725
[TBL] [Abstract][Full Text] [Related]
15. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment.
Platt L; Bobrova N; Rhodes T; Uusküla A; Parry JV; Rüütel K; Talu A; Abel K; Rajaleid K; Judd A
AIDS; 2006 Oct; 20(16):2120-3. PubMed ID: 17053361
[TBL] [Abstract][Full Text] [Related]
16. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
[TBL] [Abstract][Full Text] [Related]
17. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
[TBL] [Abstract][Full Text] [Related]
18. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
[TBL] [Abstract][Full Text] [Related]
19. Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?
de Vos AS; van der Helm JJ; Matser A; Prins M; Kretzschmar ME
Addiction; 2013 Jun; 108(6):1070-81. PubMed ID: 23347124
[TBL] [Abstract][Full Text] [Related]
20. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
